Craig Hopkinson
Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $764,837 | $3,617,908 |
| 2024 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $742,560 | $4,343,991 |
| 2023 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $714,000 | $4,226,388 |
| 2022 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $693,000 | $4,546,920 |
| 2021 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $670,000 | $4,727,478 |
| 2020 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $650,000 | $3,957,135 |
| 2019 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $621,000 | $3,656,337 |
| 2018 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $600,000 | $3,791,198 |
Earnings-call appearances
-
Alkermes plc. Q2 FY2025 Earnings Call2025-07-29
Alkermes plc. (ALKS)
-
Alkermes plc. Q1 FY2025 Earnings Call2025-05-01
Alkermes plc. (ALKS)
-
Alkermes plc. Q3 FY2023 Earnings Call2023-10-25
Alkermes plc. (ALKS)
-
Alkermes plc. Q3 FY2021 Earnings Call2021-10-27
Alkermes plc. (ALKS)